spindlewww.299pp.com
www.299pp.com 时间:2021-03-19 阅读:()
Availableonlineatwww.
ijpcr.
comInternationalJournalofPharmaceuticalandClinicalResearch2015;7(1):102-104ISSN-09751556ResearchArticle*AuthorforCorrespondenceIn-VivoAcuteDermalToxicityStudyofFormulationsonRabbits*ShetkarM.
A.
,MoreR.
R.
,KumbharS.
P.
,AuteA.
A.
,PoulB.
NDepartmentofPharmaceutics,MaharashtraCollegeofPharmacy,Nilanga,Dist.
Latur(MS)413521,IndiaAvailableOnline:1stJanuary,2015ABSTRACTPurpose:TodevelopanAceclofenactransdermalgelwithacapabilityfortopicaldrugdeliveryandThepurposeofthisstudyistoobtainscientificinformationregardinghealthhazardsthatmayresultfromaacutedermalexposuretotheagriculturalchemicalforprovidingthebasisoflayingdownthemeasureofsafetyprotectioninapplication.
Methods:Aceclofenacgelformulations,incorporatingvariouspermeationenhancers,werepreparedusingcarbomerasagellingagent.
Theformulationswereexaminedfortheirinvitrocharacteristicsincludingviscosity,pHanddrugreleaseaswellasin-vivopharmacologicalactivities.
Results:Theformulationscontaining5%ofeitherPropyleneglycolaspermeationenhancersgavedrugreleasepatternscomparabletothatofthereferenceproduct.
Propanolincreasedtheapparentviscosityofthetestgelstothesameextentasthatofthereference.
DrugreleasefromtheformulationsfittedbesttotheHiguchimodel.
Asignificantinvivoanalgesiceffectwasproducedbythetestformulationsandtheeffectwassuperiortothatobtainedwiththereferenceproduct.
Conclusion:Aceclofenacgelpreparationscontainingpropyleneglycolrespectively,exhibitedpronouncedanalgesicactivityandcouldbefurtherdevelopedfortopicaldeliveryofAceclofenac.
Keywords:Transdermalgel,toxicitystudy,PrimarydermalirritationstudyAceclofenac,PenetrationenhancerINTRODUCTIONThetestsubstanceisappliedtotheskinofthetestanimalsindifferentdosesandtheanimalsareobservedforeffectsandmortality.
Animalsshowingseveresignsoftoxicity/distressarehumanelykilled.
Attheendofthetestallsurvivinganimalsaretobesacrificed.
Necropsyisperformedonalldead,killedandsacrificedanimals.
TotesttheirritancypotentialofexperimentalAceclofenacgels,rabbitswereused,theselectedgelswereappliedtotheshavedskinontherabbitsback.
Theselectionofrabbitsforthisstudyisdescribedasfollows.
MATERIALSANDMETHODSPreparationofAceclofenacgelsRequiredquantitiesofCarbomer940,971,974weresoakedinsomeamountofdistilledwaterfor2to3hrs.
Thenitwasneutralizedbyaddingsufficientquantityoftriethanolaminewhilestirringwithhelpofoverheadstirrer(PhaseI).
Aceclofenacwasdissolvedinthemixtureofethanol(99.
9%),eitherofthePEG200,400,600andpropyleneglycol(PhaseII),Transcutol&DMSOwereaddedinsomeformulationsaspenetrationenhancers.
(PhaseII)wasaddedslowlytothe(phaseI)whilestirringwithhelpofoverheadstirrer,theremainingquantityofdistilledwaterwasthenaddedtomakeupthefinal100gmweight.
pHofallformulationswasmaintainedintherangeof6.
8to7.
4.
DeterminationofgelviscosityTheviscosityoftheformulationsandreferencewasperformedusingaBrookfielddigitalviscometer(ModelDV-II,USA)equippedwithspindleS27.
Theapparentviscositywasmeasuredat17seconds1shearrate(50rpm)androomtemperature,aftera3-minresttime.
EvaluationofinvitroibuprofenreleaseAsynthetichydrophilicmembranewasmountedonaFranzdiffusioncell(PermeGear,Riegelsville,PA,USA).
Thereceptorcompartmentcontained6.
5mLofphosphatebuffer(pH7.
4).
Onegramofthetestformulationorreferencewasappliedtothemembraneoveranareaof1.
131cm2areaacrossthedonorcompartment.
Thedonorcellwasexposedtoambienttemperatureandcoveredwithparafilmtopreventevaporation.
Thetemperatureofthereceptorcompartmentwasmaintainedat32CwhilethebuffersolutionwasstirredcontinuouslywithaTeflon-coatedmagneticbar.
Samples(0.
5ml)werewithdrawnfromthereleasemediumat0,0.
5,1,1.
5,2,3,4,6,and8handreplacedwithanequalvolumeoffreshbuffersolutiontomaintainsinkconditions.
Thesampleswereanalyzedbyhighperformanceliquidchromatography(HPLC)usingtheoperatingparametersdescribedbelow(see'HPLCanalysis').
Cumulativeamountofthedrugpermeatedversustime(Zeroorder)andalsoversussquarerootoftime(Higuchimodel)Housingandfeedingconditions:Temperature-22±3Cforrodentsand20°(±3°)forrabbitsRelativeHumidity–50-60%(However,humidityshouldnotbebelow30%orexceed70%atanygivenpointoftime).
Lighting–12hourslightanddarkcycleDietandwater–Standardlaboratorydietspecifictothespeciesandfilteredwaterfreefromcontamination.
Selectionandrandomization:Animalswererandomlyplacedincagesuponreceiptandthenrandomizedaccordingtothebodyweights,AnimalsShetkaret.
al.
/InVitroAcuteDermal…IJPCR,January2015–February2015,Volume7,Issue1,102-104Page103consideredunsuitablebecauseofoutlayingbodyweightswereexcludedfromthestudy.
Theanimalbackswerecarefullyshavedusingsterilizedshavingbladetoremovethefur.
Theselectedanimalsweregroupedinto4groups.
Andweremarkedwithidentificationcodesusingdilutedpicricacidsolution(1.
2%w/v).
Circularareasof2.
54cm(1inchdiameter)weremarkedonthebackofeachanimalusingmarkerinkonespotonrightsideandonespotonleftsideofvertebralcolumn.
Thespotonrightsidewasabradedusingshavingbladeandthespotonleftsidewaskeptintact1gmquantityoftheselectedgelswasappliedonmarkedspotsusingabsorbentcottonwool.
Thetoxicmanifestationsifanyontheskinwerethenassessedbyobservingtheskinatpre-selectedtimeintervalsaftertreatmente.
g.
1hrs,4hrs,12hrs,24hrs,48hrsand72hours,Theobservationswererecordedasnumericalscoresasforeachanimalasfollows0=novisiblereaction1=milderythema2=intenseerythema3=intenseerythemawithedema4=intenseerythemawithedemaandvesicularerosionThescorefortreatmentgroupandcontrolgroupwerethencomparedTable1:CompositionoftheAceclofenacgelformulationsNameofingredientWeight(gm)F1F2F3F4F5F6F7F8F9Aceclofenac111111111Ethanol(99.
9%)23.
9423.
9423.
9423.
9423.
9423.
9423.
9423.
9423.
94PEG40022.
4022.
4022.
4022.
4022.
4022.
4022.
4022.
4022.
40Carbopol9740.
512Carbopol971---0.
512---Carbopol9400.
512Propyleneglycol15.
5215.
5215.
5215.
5215.
5215.
5215.
5215.
5215.
52Triethanolamineq.
sq.
sq.
sq.
sq.
sq.
sq.
sq.
sq.
sDistilledwater(upto100gm\)100100100100100100100100100Table2:TheselectionofrabbitsforthisstudywithDosefortopicalApplication.
TestanimalHealthyRabbitsStrainNewZealandwhiterabbitsAge22weeksSexMaleWeight2-2.
5kgNoofanimalspergroups3animalsDoses1gmpersquareinchtopicallyNo.
ofGroupsGroupI=F1GelbasetreatedcontrolGroupII=1gmF3Formulation(withoutpenetrationenhancer)GroupIII=1gmF6Formulation(withpenetrationenhancer)DMSO1%w/w.
GroupIV=1gmF9Formulation(withpenetrationenhancer)Transcutol1%w/w,G-Gelbase,PEG200,400&Transcutol-penetrationenhancer,Carbopol974,940&971-asGellingAgentTable3:NumericalscoreforirritancypotentialforvehicletreatedcontrolGroup–I(F1Formulation)Sr.
No.
Animalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1A0000000000002B0000000000003C000000000000Shetkaret.
al.
/InVitroAcuteDermal…IJPCR,January2015–February2015,Volume7,Issue1,102-104Page104Table4:NumericalscoreforirritancypotentialforGroup-IItreatedwith[F3Formulation]whichcontainingnopenetrationenhancerSr.
No.
Animalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1D0000000000002E0000000000003F000000000000Table5:NumericalscoreforirritancypotentialforGroup-IIItreatedwith[F6Formulation]whichcontainingDMSOaspenetrationenhancerSr.
No.
Animalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1G0000000000002H0000000000003I000000000000Table6:NumericalscoreforirritancypotentialforGroup-IVtreatedwith[F9Formulation]whichcontainingTranscutolaspenetrationenhancerSr.
NoAnimalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1J0000000000002K0000000000003L000000000000RESULTSTableno1,2,3,4&5givesthesescoresforGroupI,GroupII,GroupIIIandGroupIVrespectivelyObservationsandExamination:Thefollowingfor72hrs.
Forvehiclecontrolgelbaseanimalsthosetreatedwithselectedformulationsdidn'tindicateanymanifestationofskinirritationsuchasrednessofskinorinflammationatsiteofapplication.
Boththeabradedareas&intactareaswhenappliedwithvehicleorselectedformulationwerefoundtobefreeofanysignofirritation.
Thusitcanbeconcludedthatalloftheselectedformulaearesafefortopicalapplication.
HoweverthisstudywasperformedusingasingleapplicationofgelproductsHence,itisneededtoconfirmsafetyafterrepeatedapplicationsalso.
Finding:Onlyaverysilenterythemareactionwasnotedonanimalsatexposureobservationtime.
Nodermalirritationwasnotedatthe24,48or72hourexamination.
REFERENCES1.
SethS.
D.
andMaulikM.
G.
,In;Analgesicsanti-pyreticsandanti-inflammatorydrugs,Eds;TextbookofPharmacology,1998;165.
2.
SatoskarandBhandarkar,In;Analgesic-AntipyreticsandNon-steroidalanti-inflammatorydrugs(NSAIDS)Eds;PharmacologyandPharmacoeherapeutics",1991;1(12),139-158.
3.
PalT,GanesanM.
BioavailabilityandBioequivalenceinPharmaceuticalTechnology.
India:CBSPublishers;2004.
4.
JagerW,BuchbauerG,JirovetzL,FritzerM.
PercutaneousAbsorptionofLavenderOilfromMassageOil.
JournaloftheSocietyofCosmeticChemists1992;43:49-54.
5.
PednekarPP,VakilBV,SaneRT,DatarAG.
AntimicrobialActivityofEssentialOilofBlumeaerianthaDCagainstSkinPathogens.
IntJPharmPharmSci2012;4:296-299.
6.
OrganizationforEconomicCo-operationandDevelopmentGuidelineforTestingofChemicals:RepeatedDoseDermalToxicity:21/28-DayStudy.
OECD.
1981;p.
410.
7.
SaiduYLS,BilbisML,IsezuoSA,HassanSW,AbbasAY.
AcuteAndSub-ChronicToxicityStudiesofCrudeAqueousExtractofAlbizziachevalieriharms(Leguminosae).
AsianJournalofBiochemistry2007;2:224–236.
8.
FallerC.
,BracherM.
,DamiN.
,RoguetR.
.
Predictiveabilityofreconstructedhumanepidermisequivalentsfortheassessmentofskinirritationofcosmetics.
ToxicologyinVitro2002;16,557-572.
9.
Fentem,J.
H.
,Briggs,D.
,Chesné,C.
,Elliott,G.
R.
,Harbell,J.
W.
,Heylings,J.
R.
,Portes,P.
,Roguet,R.
,vandeSandt,J.
J.
M.
&Botham,P.
A.
Aprevalidationstudyoninvitrotestsforacuteskinirritation:resultsandevaluationbytheManagementTeam.
ToxicologyinVitro2001;15,57-93.
10.
PortesP.
,GrandidierM.
-H.
,CohenC.
,RoguetR.
RefinementoftheEPISKINprotocolfortheassessmentofacuteskinirritationofchemicals:follow-uptotheECVAMprevalidationstudy.
ToxicologyinVitro2002;16,765-770
ijpcr.
comInternationalJournalofPharmaceuticalandClinicalResearch2015;7(1):102-104ISSN-09751556ResearchArticle*AuthorforCorrespondenceIn-VivoAcuteDermalToxicityStudyofFormulationsonRabbits*ShetkarM.
A.
,MoreR.
R.
,KumbharS.
P.
,AuteA.
A.
,PoulB.
NDepartmentofPharmaceutics,MaharashtraCollegeofPharmacy,Nilanga,Dist.
Latur(MS)413521,IndiaAvailableOnline:1stJanuary,2015ABSTRACTPurpose:TodevelopanAceclofenactransdermalgelwithacapabilityfortopicaldrugdeliveryandThepurposeofthisstudyistoobtainscientificinformationregardinghealthhazardsthatmayresultfromaacutedermalexposuretotheagriculturalchemicalforprovidingthebasisoflayingdownthemeasureofsafetyprotectioninapplication.
Methods:Aceclofenacgelformulations,incorporatingvariouspermeationenhancers,werepreparedusingcarbomerasagellingagent.
Theformulationswereexaminedfortheirinvitrocharacteristicsincludingviscosity,pHanddrugreleaseaswellasin-vivopharmacologicalactivities.
Results:Theformulationscontaining5%ofeitherPropyleneglycolaspermeationenhancersgavedrugreleasepatternscomparabletothatofthereferenceproduct.
Propanolincreasedtheapparentviscosityofthetestgelstothesameextentasthatofthereference.
DrugreleasefromtheformulationsfittedbesttotheHiguchimodel.
Asignificantinvivoanalgesiceffectwasproducedbythetestformulationsandtheeffectwassuperiortothatobtainedwiththereferenceproduct.
Conclusion:Aceclofenacgelpreparationscontainingpropyleneglycolrespectively,exhibitedpronouncedanalgesicactivityandcouldbefurtherdevelopedfortopicaldeliveryofAceclofenac.
Keywords:Transdermalgel,toxicitystudy,PrimarydermalirritationstudyAceclofenac,PenetrationenhancerINTRODUCTIONThetestsubstanceisappliedtotheskinofthetestanimalsindifferentdosesandtheanimalsareobservedforeffectsandmortality.
Animalsshowingseveresignsoftoxicity/distressarehumanelykilled.
Attheendofthetestallsurvivinganimalsaretobesacrificed.
Necropsyisperformedonalldead,killedandsacrificedanimals.
TotesttheirritancypotentialofexperimentalAceclofenacgels,rabbitswereused,theselectedgelswereappliedtotheshavedskinontherabbitsback.
Theselectionofrabbitsforthisstudyisdescribedasfollows.
MATERIALSANDMETHODSPreparationofAceclofenacgelsRequiredquantitiesofCarbomer940,971,974weresoakedinsomeamountofdistilledwaterfor2to3hrs.
Thenitwasneutralizedbyaddingsufficientquantityoftriethanolaminewhilestirringwithhelpofoverheadstirrer(PhaseI).
Aceclofenacwasdissolvedinthemixtureofethanol(99.
9%),eitherofthePEG200,400,600andpropyleneglycol(PhaseII),Transcutol&DMSOwereaddedinsomeformulationsaspenetrationenhancers.
(PhaseII)wasaddedslowlytothe(phaseI)whilestirringwithhelpofoverheadstirrer,theremainingquantityofdistilledwaterwasthenaddedtomakeupthefinal100gmweight.
pHofallformulationswasmaintainedintherangeof6.
8to7.
4.
DeterminationofgelviscosityTheviscosityoftheformulationsandreferencewasperformedusingaBrookfielddigitalviscometer(ModelDV-II,USA)equippedwithspindleS27.
Theapparentviscositywasmeasuredat17seconds1shearrate(50rpm)androomtemperature,aftera3-minresttime.
EvaluationofinvitroibuprofenreleaseAsynthetichydrophilicmembranewasmountedonaFranzdiffusioncell(PermeGear,Riegelsville,PA,USA).
Thereceptorcompartmentcontained6.
5mLofphosphatebuffer(pH7.
4).
Onegramofthetestformulationorreferencewasappliedtothemembraneoveranareaof1.
131cm2areaacrossthedonorcompartment.
Thedonorcellwasexposedtoambienttemperatureandcoveredwithparafilmtopreventevaporation.
Thetemperatureofthereceptorcompartmentwasmaintainedat32CwhilethebuffersolutionwasstirredcontinuouslywithaTeflon-coatedmagneticbar.
Samples(0.
5ml)werewithdrawnfromthereleasemediumat0,0.
5,1,1.
5,2,3,4,6,and8handreplacedwithanequalvolumeoffreshbuffersolutiontomaintainsinkconditions.
Thesampleswereanalyzedbyhighperformanceliquidchromatography(HPLC)usingtheoperatingparametersdescribedbelow(see'HPLCanalysis').
Cumulativeamountofthedrugpermeatedversustime(Zeroorder)andalsoversussquarerootoftime(Higuchimodel)Housingandfeedingconditions:Temperature-22±3Cforrodentsand20°(±3°)forrabbitsRelativeHumidity–50-60%(However,humidityshouldnotbebelow30%orexceed70%atanygivenpointoftime).
Lighting–12hourslightanddarkcycleDietandwater–Standardlaboratorydietspecifictothespeciesandfilteredwaterfreefromcontamination.
Selectionandrandomization:Animalswererandomlyplacedincagesuponreceiptandthenrandomizedaccordingtothebodyweights,AnimalsShetkaret.
al.
/InVitroAcuteDermal…IJPCR,January2015–February2015,Volume7,Issue1,102-104Page103consideredunsuitablebecauseofoutlayingbodyweightswereexcludedfromthestudy.
Theanimalbackswerecarefullyshavedusingsterilizedshavingbladetoremovethefur.
Theselectedanimalsweregroupedinto4groups.
Andweremarkedwithidentificationcodesusingdilutedpicricacidsolution(1.
2%w/v).
Circularareasof2.
54cm(1inchdiameter)weremarkedonthebackofeachanimalusingmarkerinkonespotonrightsideandonespotonleftsideofvertebralcolumn.
Thespotonrightsidewasabradedusingshavingbladeandthespotonleftsidewaskeptintact1gmquantityoftheselectedgelswasappliedonmarkedspotsusingabsorbentcottonwool.
Thetoxicmanifestationsifanyontheskinwerethenassessedbyobservingtheskinatpre-selectedtimeintervalsaftertreatmente.
g.
1hrs,4hrs,12hrs,24hrs,48hrsand72hours,Theobservationswererecordedasnumericalscoresasforeachanimalasfollows0=novisiblereaction1=milderythema2=intenseerythema3=intenseerythemawithedema4=intenseerythemawithedemaandvesicularerosionThescorefortreatmentgroupandcontrolgroupwerethencomparedTable1:CompositionoftheAceclofenacgelformulationsNameofingredientWeight(gm)F1F2F3F4F5F6F7F8F9Aceclofenac111111111Ethanol(99.
9%)23.
9423.
9423.
9423.
9423.
9423.
9423.
9423.
9423.
94PEG40022.
4022.
4022.
4022.
4022.
4022.
4022.
4022.
4022.
40Carbopol9740.
512Carbopol971---0.
512---Carbopol9400.
512Propyleneglycol15.
5215.
5215.
5215.
5215.
5215.
5215.
5215.
5215.
52Triethanolamineq.
sq.
sq.
sq.
sq.
sq.
sq.
sq.
sq.
sDistilledwater(upto100gm\)100100100100100100100100100Table2:TheselectionofrabbitsforthisstudywithDosefortopicalApplication.
TestanimalHealthyRabbitsStrainNewZealandwhiterabbitsAge22weeksSexMaleWeight2-2.
5kgNoofanimalspergroups3animalsDoses1gmpersquareinchtopicallyNo.
ofGroupsGroupI=F1GelbasetreatedcontrolGroupII=1gmF3Formulation(withoutpenetrationenhancer)GroupIII=1gmF6Formulation(withpenetrationenhancer)DMSO1%w/w.
GroupIV=1gmF9Formulation(withpenetrationenhancer)Transcutol1%w/w,G-Gelbase,PEG200,400&Transcutol-penetrationenhancer,Carbopol974,940&971-asGellingAgentTable3:NumericalscoreforirritancypotentialforvehicletreatedcontrolGroup–I(F1Formulation)Sr.
No.
Animalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1A0000000000002B0000000000003C000000000000Shetkaret.
al.
/InVitroAcuteDermal…IJPCR,January2015–February2015,Volume7,Issue1,102-104Page104Table4:NumericalscoreforirritancypotentialforGroup-IItreatedwith[F3Formulation]whichcontainingnopenetrationenhancerSr.
No.
Animalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1D0000000000002E0000000000003F000000000000Table5:NumericalscoreforirritancypotentialforGroup-IIItreatedwith[F6Formulation]whichcontainingDMSOaspenetrationenhancerSr.
No.
Animalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1G0000000000002H0000000000003I000000000000Table6:NumericalscoreforirritancypotentialforGroup-IVtreatedwith[F9Formulation]whichcontainingTranscutolaspenetrationenhancerSr.
NoAnimalcode1hrs4hrs12hrs24hrs48hrs72hrsIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbradedIntactAbraded1J0000000000002K0000000000003L000000000000RESULTSTableno1,2,3,4&5givesthesescoresforGroupI,GroupII,GroupIIIandGroupIVrespectivelyObservationsandExamination:Thefollowingfor72hrs.
Forvehiclecontrolgelbaseanimalsthosetreatedwithselectedformulationsdidn'tindicateanymanifestationofskinirritationsuchasrednessofskinorinflammationatsiteofapplication.
Boththeabradedareas&intactareaswhenappliedwithvehicleorselectedformulationwerefoundtobefreeofanysignofirritation.
Thusitcanbeconcludedthatalloftheselectedformulaearesafefortopicalapplication.
HoweverthisstudywasperformedusingasingleapplicationofgelproductsHence,itisneededtoconfirmsafetyafterrepeatedapplicationsalso.
Finding:Onlyaverysilenterythemareactionwasnotedonanimalsatexposureobservationtime.
Nodermalirritationwasnotedatthe24,48or72hourexamination.
REFERENCES1.
SethS.
D.
andMaulikM.
G.
,In;Analgesicsanti-pyreticsandanti-inflammatorydrugs,Eds;TextbookofPharmacology,1998;165.
2.
SatoskarandBhandarkar,In;Analgesic-AntipyreticsandNon-steroidalanti-inflammatorydrugs(NSAIDS)Eds;PharmacologyandPharmacoeherapeutics",1991;1(12),139-158.
3.
PalT,GanesanM.
BioavailabilityandBioequivalenceinPharmaceuticalTechnology.
India:CBSPublishers;2004.
4.
JagerW,BuchbauerG,JirovetzL,FritzerM.
PercutaneousAbsorptionofLavenderOilfromMassageOil.
JournaloftheSocietyofCosmeticChemists1992;43:49-54.
5.
PednekarPP,VakilBV,SaneRT,DatarAG.
AntimicrobialActivityofEssentialOilofBlumeaerianthaDCagainstSkinPathogens.
IntJPharmPharmSci2012;4:296-299.
6.
OrganizationforEconomicCo-operationandDevelopmentGuidelineforTestingofChemicals:RepeatedDoseDermalToxicity:21/28-DayStudy.
OECD.
1981;p.
410.
7.
SaiduYLS,BilbisML,IsezuoSA,HassanSW,AbbasAY.
AcuteAndSub-ChronicToxicityStudiesofCrudeAqueousExtractofAlbizziachevalieriharms(Leguminosae).
AsianJournalofBiochemistry2007;2:224–236.
8.
FallerC.
,BracherM.
,DamiN.
,RoguetR.
.
Predictiveabilityofreconstructedhumanepidermisequivalentsfortheassessmentofskinirritationofcosmetics.
ToxicologyinVitro2002;16,557-572.
9.
Fentem,J.
H.
,Briggs,D.
,Chesné,C.
,Elliott,G.
R.
,Harbell,J.
W.
,Heylings,J.
R.
,Portes,P.
,Roguet,R.
,vandeSandt,J.
J.
M.
&Botham,P.
A.
Aprevalidationstudyoninvitrotestsforacuteskinirritation:resultsandevaluationbytheManagementTeam.
ToxicologyinVitro2001;15,57-93.
10.
PortesP.
,GrandidierM.
-H.
,CohenC.
,RoguetR.
RefinementoftheEPISKINprotocolfortheassessmentofacuteskinirritationofchemicals:follow-uptotheECVAMprevalidationstudy.
ToxicologyinVitro2002;16,765-770
- spindlewww.299pp.com相关文档
- 8.www.299pp.com
- Ilwww.299pp.com
- MAXwww.299pp.com
- vFQwww.299pp.com
- putwww.299pp.com
- Int.J.Curr.Microbiol.App.Sci
RackNerd 黑色星期五5款年付套餐
RackNerd 商家从2019年上线以来争议也是比较大的，一直低价促销很多网友都认为坚持时间不长可能会跑路。不过，目前看到RackNerd还是在坚持且这次黑五活动也有发布，且活动促销也是比较多的，不过对于我们用户来说选择这些低价服务商尽量的不要将长远项目放在上面，低价年付套餐服务商一般都是用来临时业务的。RackNerd商家这次发布黑五促销活动，一共有五款年付套餐，涉及到多个机房。最低年付的套餐...
LightNode($7.71/月)香港cn2精品线路
LightNode官网LightNode是一家位于香港的VPS服务商.提供基于KVM虚拟化技术的VPS.在提供全球常见节点的同时，还具备东南亚地区、中国香港等边缘节点.满足开发者建站，游戏应用，外贸电商等应用场景的需求。为用户带来高性能服务器以及优质的服务的同时还提供丰厚的促销活动，新用户注册最高送$20。注册用户带新客即可得10%返佣。商家支持PayPal，支付宝等支付方式。官网：https:/...
CloudCone2核KVM美国洛杉矶MC机房机房2.89美元/月，美国洛杉矶MC机房KVM虚拟架构2核1.5G内存1Gbps带宽，国外便宜美国VPS七月特价优惠
近日CloudCone发布了七月的特价便宜优惠VPS云服务器产品，KVM虚拟架构，性价比最高的为2核心1.5G内存1Gbps带宽5TB月流量，2.89美元/月，稳定性还是非常不错的，有需要国外便宜VPS云服务器的朋友可以关注一下。CloudCone怎么样？CloudCone服务器好不好？CloudCone值不值得购买？CloudCone是一家成立于2017年的美国服务器提供商，国外实力大厂，自己开...
www.299pp.com为你推荐
-
特朗普取消访问丹麦特朗普首次出访为什么选择梵蒂冈7788k.comwww.k6320.com 大家给我看看这网站是真是假...杰景新特杰德特这个英雄怎么样rawtoolsRAW是什么衣服牌子罗伦佐娜罗拉芳娜 （西班牙小姐）谁可以简单的介绍以下同ip域名不同的几个ip怎样和同一个域名对应上ip在线查询通过对方的IP地址怎么样找到他的详细地址?789se.comwuwu8.com这个站长是谁？www.175qq.com这表情是什么？www.diediao.com谁知道台湾的拼音怎么拼啊？有具体的对照表最好！